glp 1 schizophrenia Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight and other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September Doctors and patients across social

Can L-arginine improve exercise performance in older adults

It is produced in a state-of-the-art facility, following strict quality control standards to guarantee purity and safety

You dont need to be on TRT to benefit from better antioxidant status and cellular protection

When you [take our free assessment quiz], you embark on a journey where such intricate details are managed by experienced professionals, allowing you to focus on your progress with peace of mind

July-August 2021

Diabetol Metab Syndr 17(1):315 McCrimmon RJ, Catarig AM, Frias JP, Lausvig NL, le Roux CW, Thielke D et al (2020) Effects of once-weekly semaglutide vs once-daily Canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial